Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $28.1 Million - $35.6 Million
-261,900 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $27.9 Million - $31.6 Million
261,900 New
261,900 $28.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.